Francisco Carlos P. M.
- Country
- Spain
- Department
- Neurology
Research Overview
- Phase I Study on Safety, Tolerability, and Efficacy of OBE-CEL in Refractory Progressive Multiple Sclerosis
- Efficacy and Safety of Remibrutinib in Patients with Secondary Progressive Multiple Sclerosis: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- Phase 3 Randomized Double‑Blind Study of Orelabrutinib vs Placebo on Disability Progression in Non‑Active Secondary Progressive Multiple Sclerosis
Data & Insights
Has run more than one trial at 254 of 484 partner sites.
Specializations
Multiple Sclerosis Research
This investigator specializes in the treatment of relapsing multiple sclerosis (RMS) and relapsing-remitting multiple sclerosis (RRMS), with particular emphasis on developing innovative therapeutic approaches for patients with breakthrough disease activity.
- Advanced MS Therapeutics
- Novel Treatment Evaluation
- Disease Activity Management
The investigator's work encompasses cellular therapy applications and comparative treatment assessments in multiple sclerosis care.
Neurological Therapeutics
Focused on evaluating pharmacokinetics and pharmacodynamics of various therapeutic agents in neurological conditions, with specific attention to treatment responses in multiple sclerosis patients.
- Therapeutic Agent Comparison
- Clinical Effects Assessment
- Safety Profile Analysis
The research involves assessment of brain lesion suppression and therapeutic response monitoring in MS patients.
Clinical Safety Studies
Expertise in conducting safety assessments of new therapeutic agents, particularly focusing on treatments for patients who have experienced breakthrough disease activity during previous therapeutic interventions.
- Dose Escalation Studies
- Treatment Safety Profiles
- Long-term Monitoring
The investigator evaluates therapeutic safety in the context of highly efficacious MS treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.